Ipsen
The Principal Scientist - Immunogenicity is a senior scientific role within Ipsen’s Early Development/Clinical Pharmacology, DMPK & Pharmacometrics organization focused on immunogenicity and immunoanalysis for the company’s biologics portfolio. The position is based at the Dreux laboratories and involves working closely with cross‑functional teams and external partners to advance immunogenicity science. It offers an opportunity to contribute scientific leadership in a collaborative, innovation‑driven environment.
Headquarters
Paris, Île-De-France, France
Company Size
5001-10000 employees
Founded
1929
Ipsen is a global biopharmaceutical company focused on innovation and specialty care to improve the lives of patients around the world.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Ipsen.
Ipsen didn’t post a salary, so this is our estimate from similar listings.
IPSEN (OTCMKTS:IPSEY) Stock Crosses Above Two Hundred Day Moving Average - Here's What Happened
9 hours ago